Market Newsdesk

JEFFERSON CITY, Mo., Sept. 10, 2026 (GLOBE NEWSWIRE) — Hawthorn Bancshares, Inc. (NASDAQ: HWBK) and Hawthorn Bank are deeply saddened to announce the passing of Jonathan “Jon” Holtaway, a member of the Company’s Board of Directors since 2019. Mr. Holtaway passed away on September 4, 2026, at the age of 55.

“Jon was an exceptional director, advisor and friend,” said Brent Giles, Chairman and Chief Executive Officer of Hawthorn Bancshares and Hawthorn Bank. “He brought extraordinary insight, wisdom and sound judgment to every discussion, and his counsel helped guide important decisions at Hawthorn. Jon had a deep understanding of community banking and a thoughtful, long-term perspective that challenged us to think strategically and encouraged us to pursue opportunities for growth. We are grateful for his service, his friendship and the lasting impact he made on our organization. We will deeply miss his presence.”

Mr. Holtaway was President of Ategra Capital Management, LLC, a registered investment advisory firm based in Virginia that he founded in 2005. He also served as managing member of Ategra GP, LLC, the general partner of Ategra Community Financial Institution Fund, LP, which invests primarily in securities of companies in the bank and thrift industry, and Ategra LS500, LP, which invests primarily in large-capitalization equities.

Throughout his career, Mr. Holtaway earned broad respect in the banking industry for his expertise in strategic planning, mergers and acquisitions, equity valuation and corporate governance. He was also a frequent speaker at banking industry conferences and the author of The Growth Penalty: Unfinished Business, Banking and the American Recovery, published in 2013.

A graduate of the University of Pennsylvania’s Wharton School, Mr. Holtaway earned a bachelor’s degree in economics.

“While Jon’s professional accomplishments were significant, those of us who had the privilege of knowing him will remember him just as much for his humility, generosity, curiosity and genuine care for the people around him,” Giles said. “He was someone who made those around him better, and his loss will be felt throughout Hawthorn.”

The Board of Directors, management team and employees of Hawthorn Bancshares and Hawthorn Bank extend their heartfelt condolences to Jon’s family, friends and colleagues.

About Hawthorn Bancshares, Inc.

Hawthorn Bancshares, Inc. (NASDAQ: HWBK) is a financial holding company headquartered in Jefferson City, Missouri, and the parent company of Hawthorn Bank. Hawthorn Bank provides a broad range of commercial and consumer banking services, including deposit accounts, loans, treasury management services, and wealth services, to individuals and businesses across Missouri through its network of banking locations. Hawthorn is focused on delivering relationship-based community banking and supporting the financial needs of the communities it serves.

Contact:

Hawthorn Bancshares, Inc.

Brent M. Giles
Chief Executive Officer
TEL: 573.761.6100
www.HawthornBancshares.com

CENTENNIAL, Colo., Sept. 10, 2026 (GLOBE NEWSWIRE) — PVG Asset Management Corp. (“PVG”), a stockholder of Anavex Life Sciences Corp. (NASDAQ: AVXL) (“Anavex” or the “Company”), today announced that it will host an investor conference call to discuss its campaign for change in the Anavex Board of Directors at the upcoming 2026 Annual Meeting of Stockholders.

During the call, PVG will discuss its views regarding the Company’s recent performance, corporate governance, capital markets strategy, leadership transition, clinical development priorities, and the rationale for electing PVG’s six highly qualified nominees to the Company’s Board of Directors.

Investor Call Details

Date: Wednesday, September 16, 2026
Time: 10:00 a.m. Eastern Time
Webcast/Conference Call:https://edge.media-server.com/mmc/go/pvg2026townhall
Replay Information:https://edge.media-server.com/mmc/go/pvg2026townhall

PVG believes Anavex’s valuable clinical assets require experienced leadership, enhanced capital markets credibility, and stronger board oversight to maximize stockholder value. The investor call will provide stockholders with an opportunity to hear directly from PVG representatives regarding the firm’s plan to improve governance, strengthen strategic execution, and position the Company for future success.

“Anavex stockholders are facing an important decision at this year’s Annual Meeting,” said Patrick S. Adams, President of PVG Asset Management Corporation. “We believe the Company requires a new Board and an experienced biotechnology CEO capable of restoring credibility with investors, securing the capital necessary to advance key clinical programs, and creating long-term value for all stockholders. We look forward to discussing our views and answering stockholder questions during the call.”

PVG encourages all stockholders to carefully review its proxy materials and vote the GOLD Universal Proxy Card to elect PVG’s six nominees at the 2026 Annual Meeting.

For additional information regarding PVG’s campaign for change at Anavex, please visit:

www.AnavexVotePVG.com

Participants in the Solicitation

The participants in PVG’s solicitation of proxies are PVG Asset Management Corporation, Patrick S. Adams, Jason Kolbert, Ralf von Ziegesar, Rene Mora, John Boris and Curtis Hogue (collectively, the “Participants”). Information concerning the identity of the Participants and a description of their direct or indirect interests, by security holdings or otherwise, is included in PVG’s Definitive Proxy Statement and related SEC filings.

Forward-Looking Statements

 This release and any related communications contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements that are not historical facts, including statements regarding PVG’s plans, objectives, beliefs, strategies and expectations relating to the 2026 Annual Meeting, the proxy solicitation, the Company, the Company Board of Directors, the PVG nominees, stockholder value and the potential outcome of PVG’s solicitation.

These statements may be identified by words such as “believes,” “expects,” “anticipates,” “plans,” “intends,” “estimates,” “may,” “will,” “would,” “could,” “should” and similar expressions, or the negative thereof. Actual results may differ materially from those projected or contemplated by these forward-looking statements due to various risks and uncertainties, including those described in applicable filings made by the Company and PVG with the SEC.

Stockholders are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date made. PVG and the Participants do not undertake any obligation to update or revise any forward-looking statements, except as required by applicable law.

Important Additional Information and Where to Find It

PVG, together with the other Participants, has filed a definitive proxy statement on Schedule 14A and accompanying GOLD Universal Proxy Card with the SEC in connection with the solicitation of proxies from stockholders of the Company relating to the 2026 Annual Meeting.

STOCKHOLDERS ARE STRONGLY ENCOURAGED TO READ THE DEFINITIVE PROXY STATEMENT, THE ACCOMPANYING GOLD UNIVERSAL PROXY CARD, ANY AMENDMENTS OR SUPPLEMENTS THERETO, AND ANY OTHER DOCUMENTS FILED BY PVG WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY BEFORE MAKING ANY VOTING DECISION BECAUSE THEY CONTAIN IMPORTANT INFORMATION.

The Definitive Proxy Statement, GOLD Universal Proxy Card and other relevant materials filed by PVG with the SEC are available at no charge at the SEC’s website at https://www.sec.gov/. 
  

Contact:


Patrick S. Adams
PVG Asset Management Corporation
[email protected] 

LOS ANGELES, Sept. 10, 2026 (GLOBE NEWSWIRE) — Lineage, Inc. (NASDAQ: LINE) today filed a civil lawsuit in Los Angeles Superior Court against Altus Power, Inc., a commercial solar operator, and its contractor Pearce Services LLC, a subsidiary of CBRE Group, alleging that their negligence caused the June 17, 2026, fire that destroyed Lineage’s 500,000 square-foot cold storage facility in the Boyle Heights neighborhood in Los Angeles.

Key
points
from
the
suit:

• Altus and Pearce’s negligence started the fire. They abandoned Lineage to clean up the site on their own and ignored the Boyle Heights community. This was a solar fire, not a warehouse fire.
• Altus was and is the owner of the solar array, and this was not Altus’ first fire at the facility. In August 2024, the same solar array sparked a smaller fire on the facility’s roof. Following that incident, Lineage called for enhanced safety measures before the array could be re-energized, and Altus retained Pearce to reconfigure the array. By May 2026, more than 200 connector failures had been identified across the array, including in the section where the June fire would begin.
• Altus and Pearce disregarded Lineage’s written safety directives and re-energized a defective rooftop solar array before required safety checks were completed – days before the fire.
• On June 11, 2026, Lineage notified Altus in writing that the system should not be re-energized until critical safety tests were completed. Altus and Pearce deliberately ignored those instructions. Beginning on June 5 and continuing through June 17, the array was energized without completing the required testing and before all work on the array had been completed. The fire ignited on June 17 while Pearce personnel were working on the energized system.
• When the community needed direct assistance and the site cleaned up, Altus and Pearce did nothing. Lineage has a longstanding track record of operating with the highest degree of integrity backed by the Company’s commitments to the communities and customers it serves. Since the fire began, Lineage has provided community support including direct financial assistance, relocation, air conditioners, air purifiers and grocery cards. With the cleanup completed, Lineage’s commitment to the community of Boyle Heights continues, and the Company remains dedicated to ongoing and transparent communication with neighbors and local community organizations to understand ongoing needs.

“This lawsuit is about Altus and Pearce starting this fire and then being nowhere to be found when the community needed help,” said Greg Lehmkuhl, President & CEO of Lineage. “From the moment it started, Lineage stood alone in supporting remediation and cleanup efforts for a neighborhood impacted through absolutely no fault of our own. The record is clear: this was a solar fire. Cold storage is not a risk to communities – it is an essential service that lowers food costs, expands food access and creates jobs. We are grateful to each and every worker who contributed over 210,000 hours to complete this unprecedented and complex cleanup in record time. We want to thank the community of Boyle Heights and East LA for their patience during this process. With the cleanup completed, now is the right time to pursue accountability and recover the substantial losses we incurred as a result of Altus’s and Pearce’s negligence.”

For more information, please visit: https://www.onelineage.com/boyle-heights-fire-response.

About
Lineage,
Inc.

Lineage, Inc. (NASDAQ: LINE) partners with food and beverage producers, retailers, and distributors to help increase distribution efficiency, advance sustainability, minimize supply chain waste, and, most importantly, feed the world. Learn more at onelineage.com and join us
on LinkedIn, Facebook, Instagram, and X.

Forward-Looking Statements

Certain statements contained in this press release may be considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Lineage intends for all such forward-looking statements to be covered by the applicable safe harbor provisions for forward-looking statements contained in those acts. Such forward-looking statements can generally be identified by Lineage’s use of forward-looking terminology such as “may,” “will,” “expect,” “intend,” “anticipate,” “estimate,” “believe,” “continue,” “seek,” “objective,” “goal,” “strategy,” “plan,” “focus,” “priority,” “should,” “could,” “potential,” “possible,” “look forward,” “optimistic,” or other similar words. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Such statements are subject to certain risks and uncertainties, including known and unknown risks, which could cause actual results to differ materially from those projected or anticipated. Therefore, such statements are not intended to be a guarantee of Lineage’s performance in future periods. Except as required by law, Lineage does not undertake any obligation to update or revise any forward-looking statements contained in this release.

While the forward-looking statements are considered reasonable by the Company, they are subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond the control of the Company and cannot be predicted with accuracy and may not be realized. There can be no assurance that the forward-looking statements can or will be attained or maintained. Actual operating results may vary materially from the forward-looking statements included in this Press Release.

Media
Contact

Megan Klein
VP, Global Marketing & Communications
[email protected]

MEMPHIS, Tenn., Sept. 10, 2026 (GLOBE NEWSWIRE) — Today, AutoZone, Inc. (NYSE: AZO) celebrated the opening of its 8,000^th store, located in Murfreesboro, Tennessee, reaffirming its long-standing commitment to providing the best auto parts at the right price.

This milestone highlights 47 years of steady growth for a leading retailer and distributor of automotive parts and accessories, marking AutoZone’s journey from a single store opened on July 4, 1979, in Forrest City, Arkansas, to 8,000 locations across the Americas.

“We are deeply committed to our core purpose of helping customers keep their vehicles on the road through Trustworthy Advice, quality products and exceptional customer service,” said Phil Daniele, President and Chief Executive Officer, Customer Satisfaction, AutoZone. “Achieving this milestone was made possible by the dedication of our incredible AutoZoners, the loyalty of our customers and the trust of the communities we serve.”

The new Murfreesboro store will provide local drivers and commercial businesses with convenient access to thousands of automotive replacement parts and maintenance items. Additionally, AutoZone will proudly offer its signature services at this location, including free battery testing and charging, Fix Finder^® diagnostic services and the popular Loan-A-Tool^® program.

“Store number 8,000 is not the finish line,” said Daniele. “It reflects nearly five decades of growth driven by staying true to our Pledge and Values, investing in our AutoZoners and remaining focused on serving customers—our greatest opportunities are still ahead.”

To celebrate the occasion, AutoZone hosted a grand opening ceremony featuring an official ribbon cutting with AutoZone leaders, Tennessee Governor Bill Lee and Senator Marsha Blackburn. First opened in 1979 as Auto Shack by J.R. “Pitt” Hyde III, AutoZone has a long history of Going the Extra Mile for its customers and communities.

About AutoZone (NYSE: AZO)

As of August 29, 2026, AutoZone had 6,863 stores in the U.S., 1,001 in Mexico and 167 in Brazil, for a total store count of 8,031.

AutoZone is a leading retailer and distributor of automotive replacement parts and accessories in the Americas. Each store carries an extensive product line for cars, sport utility vehicles, vans and light duty trucks, including new and remanufactured automotive hard parts, maintenance items, accessories, and non-automotive products. The majority of stores have a Commercial sales program that provides prompt delivery of parts and other products and Commercial credit to local, regional and national repair garages, dealers, service stations, fleet owners and other accounts. AutoZone also sells automotive hard parts, maintenance items, accessories and non-automotive products through www.AutoZone.com, and our Commercial customers can make purchases through www.AutoZonePro.com. Additionally, we sell the ALLDATA brand of automotive diagnostic, repair, collision and shop management software through www.ALLDATA.com. We also provide product information on our Duralast-branded products through www.DuralastParts.com. AutoZone does not derive revenue from automotive repair or installation services.

Contact Information:

Financial: Brian Campbell at (901) 495-7005, [email protected]

Media: Jennifer Hughes at (901) 495-6022, [email protected]

DENVER, Sept. 10, 2026 (GLOBE NEWSWIRE) — The biotech tape delivered a brutal reminder of one of the sector’s oldest rules: even a fundamentally strong company can get caught in the crossfire when a major drugmaker suffers a pipeline setback. Yesterday, a setback at Novartis (NYSE: NVS) sent ripples across the biotech space, pressuring companies whose own clinical and corporate announcements remained decidedly positive.

The resulting selloff highlighted just how quickly investors can shift from company-specific fundamentals to broader sector risk. For smaller biotech names, that indiscriminate pressure can be painful, but it can also create potentially compelling rebound setups when positive catalysts remain intact and the underlying thesis has not materially changed.

When Novartis’ Phase 3 Lp(a)HORIZON study for pelacarsen fell short on cardiovascular events, despite successfully lowering Lp(a), and del-desiran’s Phase 3 HARBOR primary endpoint, Novartis shares suffered one of their worst-ever daily declines and also pressured companies developing unrelated therapies.

That is where the setup gets interesting for smaller biotech names. The market demonstrated that it is willing to sell first and differentiate later. For traders hunting the next leg rather than chasing yesterday’s winners, that kind of indiscriminate pressure can create exactly the type of dislocation worth watching.

Novartis: 2 Missed Expectations, 1 Massive Sector Shock

Novartis (NYSE:NVS) became the epicenter of the current biotech risk-off wave. Pelacarsen failed to demonstrate a reduction in cardiovascular events even though it achieved substantial Lp(a) lowering, challenging assumptions surrounding one of the industry’s most closely watched emerging cardiovascular targets. Novartis said the findings provide “important new evidence” about the relationship between Lp(a) lowering and cardiovascular outcomes.

Then the second shoe dropped. Del-desiran failed to achieve the primary endpoint in the Phase 3 HARBOR study in myotonic dystrophy type 1. Novartis said the drug showed evidence of activity in secondary endpoints and exploratory analyses, but the primary endpoint, video hand opening time, was not statistically significant versus placebo.

The market reaction was severe. Reuters reported that the del-desiran news sent Novartis shares down roughly 10.9% in one session and erased about $32 billion in market value. The company has maintained its 5%-6% five-year sales CAGR guidance, but investors are now looking much harder at the remaining pipeline.

For the broader biotech market, however, the important takeaway may be less about Novartis itself and more about correlation risk. When a major drugmaker disappoints, investors frequently punish companies sharing a mechanism, indication or perceived development theme, even when those smaller companies have independent data. That creates both danger and opportunity.

That Juxtaposition is the Story

The following are some of the companies that produced legitimate wins and were held down, as the unrelated news traveled directly down the market-cap spectrum. Traders should distinguish between a company whose own thesis has broken and a company that simply got caught in a sector-wide liquidation. Those are two very different setups and the rebound becomes the play.

NeOnc Technologies Holdings: $15M Funding Sets New Number to Watch

NeOnc (NASDAQ:NTHI) enters the rebound conversation with something many small biotechs desperately need: clinical data plus fresh capital. The company recently reported Phase 2a results for intranasal NEO100 in recurrent or progressive Grade III and Grade IV IDH1-mutant glioma. Six-month progression-free survival was 48.9%, versus a prespecified 20% benchmark, with a reported p-value of 0.0047. Median overall survival was 26.09 months.

Then came the financing. NeOnc announced a roughly $15 million registered direct offering priced at $4.20 per share, or pre-funded warrants in certain cases, with accompanying warrants also exercisable at $4.20. The transaction was described as priced at-the-market under Nasdaq rules.

The $4.20 figure is therefore a key reference point. It is reasonable for traders to view an at-the-market institutional financing price as a potentially meaningful valuation reference that the company is intrinsically worth more than $4.20.

The clinical catalyst remains the bigger story. NeOnc plans to request a Type B FDA meeting to discuss a potential registrational pathway for NEO100. If the broader biotech tape stabilizes, NTHI has the ingredients for a rebound narrative: fresh financing, a defined clinical catalyst and a previously reported efficacy signal.

Tenon Medical: Dilution Overhang Eliminated

Tenon (NASDAQ:TNON) offers a different type of setup. The company announced that it repaid its approximately $5.16 million of outstanding original-issue-discount senior convertible notes ahead of their September 11 maturity date. The notes were issued in March and had the potential to convert into common shares at a discount to market prices.

That matters because small-cap traders often focus on the clinical or commercial catalyst while ignoring the capital structure. Convertible debt can become a persistent source of selling pressure when holders have an economic incentive to convert shares below prevailing market prices.

Tenon’s repayment removes that particular overhang. CEO Steven M. Foster said: “By proactively addressing this obligation, we are reducing potential dilution for our shareholders, strengthening our financial position and maintaining greater flexibility to invest in the continued commercialization of our products and expansion of our business.”

That doesn’t magically eliminate execution risk, but it changes the trading equation.

Opus Genetics: Positive Data Meets a Brutal Biotech Tape

Opus Genetics (NASDAQ:IRD) may be one of the clearest examples of the market’s current disconnect between company-specific news and sector-level price action. The company reported positive three- and six-month results from Cohort 1 of its Phase 1/2 BIRD-1 study evaluating OPGx-BEST1 in BEST1-related inherited retinal diseases. All five participants demonstrated clinically meaningful improvements in at least one visual-function measure, while structural improvements were observed in four participants.

The company reported best-corrected visual-acuity improvement in three of five participants and improved retinal sensitivity by microperimetry in three of four evaluable participants. No serious adverse events or dose-limiting toxicities were reported in the cohort, according to the company.

More importantly for the forward-looking story, Opus has been working toward a potential pivotal program. The company previously said its FDA interactions could support a pivotal endpoint involving microperimetry and a patient-reported outcome, with potential Phase 3 dosing targeted for 2027.

That creates the kind of setup where consolidation could matter more than another headline spike. After a big move, digestion of gains can establish a new base; if the stock holds that base while the pipeline continues advancing, another leg becomes technically possible.

About 24/7 Market News

In today’s fast-moving markets, visibility is everything and 24/7 Market News (24/7) provides a powerful suite of investor relations and public relations solutions designed to elevate your company’s profile quickly and effectively. Whether you’re an established name seeking broader awareness, or a micro-cap looking to break out of obscurity, 24/7 delivers targeted, high-impact coverage through timely news distribution, analyst report placements, featured editorials, and multi-channel amplification across financial platforms, social media, and investor communities. Our services help cut through the noise, attract institutional interest, drive exposure, and build long-term shareholder credibility, all while maintaining full SEC compliance and transparency. For Analyst Report coverage, custom IR campaigns, press release syndication, or other tailored investor and public relations solutions, contact [email protected] to discuss how 24/7 can help accelerate your company’s visibility and valuation trajectory.

This is a paid editorial communication intended for informational purposes only. 24/7 is compensated by NTHI to provide ongoing news coverage of expected upcoming catalysts and events as well as market outreach services. For further disclosure information, please click here. This should not be construed as financial or investment advice. Trading involves substantial risk; consult your financial advisor.

Important Editorial Note: 247 highlights companies approaching significant catalysts and inflection points. This report reflects information available at the time of publication. Since developments can occur rapidly, readers should independently verify current information and review all company filings and disclosures.

CONTACT:

24/7 Market News
[email protected]

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding the Company’s ability to grow its business and other statements that are not historical facts, including statements which may be accompanied by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Actual results could differ materially from those described in these forward-looking statements due to a number of factors, including without limitation, the Company’s ability to continue as a going concern, general economic conditions, and other risk factors detailed in the Company’s filings with the SEC. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility to update such forward-looking statements except in accordance with applicable law.